FATE Stock Jumps 6% As FDA Greenlights Moving Cell Therapy To Clinical Trials

Fate’s off-the-shelf CAR-T therapy shows early promise in treatment-resistant autoimmune disease

“We were not expecting to see clinical responses so early,” Vaneet Sandhu, M.D., rheumatologist and vice president of clinical development a

STAT+: FDA approves Vera Therapeutics kidney disease treatment

The FDA approved a new medicine from the biotech company Vera Therapeutics for patients with a type of chronic autoimmune kidney disease.

<![CDATA[Inotuzumab Ozogamicin Shows MRD Clearance in B-Cell ALL Trial]]>

A revolutionary cancer treatment could transform autoimmune disease

Researchers are testing CAR T cell therapy as a way to reset the immune system in lupus, Graves’ disease and other conditions where the body

Autoimmune Disease Therapies Market Booms as AbbVie's Skyrizi Poised to Become Second-Best Selling Drug

In this week’s edition of InnovationRx, we look at the boom in autoimmune disease therapies, OpenAI’s healthcare push, Vertex’s $10 billion

Medipost's Cartistem Begins U.S. Phase 3, Doses First Patient

Medipost has dosed its first patient in the U.S. Phase 3 trial of Cartistem, its knee osteoarthritis stem cell therapy, targeting 300 patien